Tamil Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.50 M
- Company Age 4 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
About Tamil Pharma
Tamil Pharma Private Limited (TPPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 July 2020 (Four years and seven months 12 days old ). Its registered office is in Karur, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M, as per Ministry of Corporate Affairs (MCA) records.
Sivasubramaniam Muthukumar, Muthukumar Praveena, Veeran Raja, and Two other members serve as directors at the Company.
Company Details
- Location
Karur, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24100TN2020PTC136337
- Company No.
136337
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Jul 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Tamil Pharma?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sivasubramaniam Muthukumar  | Director | 12-Jul-2020 | Current |
| Muthukumar Praveena | Director | 16-Aug-2020 | Current |
| Veeran Raja | Director | 16-Aug-2020 | Current |
| Ponraj Sukanya | Director | 12-Jul-2020 | Current |
| Jagadeesan Kumar | Director | 12-Jul-2020 | Current |
Financial Performance of Tamil Pharma.
Tamil Pharma Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Tamil Pharma?
In 2021, Tamil Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vmd Textile Park Private LimitedMuthukumar Praveena is a mutual person
- Yasmina Healthcare Private Limited
Ponraj Sukanya is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Tamil Pharma?
Tamil Pharma has a workforce of 0 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tamil Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tamil Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.